Items where authors include "Coates, L."

Number of items: 27.

Article

Roberts, T., Hirst, R., Birse, F. et al. (97 more authors) (2024) Subarachnoid haemorrhage in the emergency department (SHED): a prospective, observational, multicentre cohort study. Emergency Medicine Journal, 41 (12). pp. 719-727. ISSN 1472-0205

McHugh, N., Tillett, W., Helliwell, P. orcid.org/0000-0002-4155-9105 et al. (7 more authors) (2024) Enhanced surveillance for the detection of psoriatic arthritis in a UK primary care psoriasis population: results from the TUDOR trial. Rheumatology. keae374. ISSN 1462-0324

Brady, S. orcid.org/0000-0001-7763-2776, Mott, A. orcid.org/0000-0001-7844-9033, Carlisle, K. et al. (21 more authors) (2024) PERI-operative biologic DMARD management: stoppage or COntinuation during orthoPaEdic operations (the PERISCOPE trial) – a study protocol for a pragmatic, UK multicentre, superiority randomised controlled trial with an internal pilot, economic evaluation and nested qualitative study. BMJ Open, 14 (6). e084997. ISSN 2044-6055

Brady, S., Mott, A., Carlisle, K. et al. (21 more authors) (2024) PERI-operative biologic DMARD management: Stoppage or COntinuation during orthoPaEdic operations (the PERISCOPE trial) – a study protocol for a pragmatic, UK multicentre, superiority randomised controlled trial with an internal pilot, economic evaluation and nested qualitative study. BMJ Open, 14 (6). e084997. ISSN 2044-6055

Hailey, L., Bundy, C., Burstow, H. et al. (13 more authors) (2023) The top 10 research priorities in psoriatic arthritis: a James Lind Alliance Priority Setting Partnership. Rheumatology, 62 (8). pp. 2716-2723. ISSN 1462-0324

Abhishek, A., Boyton, R.J., McKnight, Á. et al. (15 more authors) (2022) Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study). BMJ Open, 12 (5). e062599. ISSN 2044-6055

Totton, N., Julious, S. orcid.org/0000-0002-9917-7636, Hughes, D. et al. (6 more authors) (2021) Utilising benefit-risk assessments within clinical trials—a protocol for the BRAINS project. Trials, 22. 68. ISSN 1745-6215

Elmamoun, M., Eraso, M., Anderson, M. et al. (23 more authors) (2020) International league of associations for rheumatology recommendations for the management of psoriatic arthritis in resource-poor settings. Clinical Rheumatology, 39 (6). pp. 1839-1850. ISSN 0770-3198

Wessels, B., Taylor, J. and Coates, L. (2017) Telehealth in Community Nursing: A Negotiated Order. Sociological Research Online, 22 (4). pp. 152-168. ISSN 1360-7804

Brennan, A., Pollard, D. orcid.org/0000-0001-5630-0115, Coates, L. et al. (2 more authors) (2017) PRM252 - Expected Value of Sample Information For Individual Level Simulation Models To Inform Stop/Go Decision Making By Public Research Funders: A Methodology for The Dafneplus Diabetes Education Cluster Rct. Value in Health, 20 (9). A776-A776. ISSN 1098-3015

Conference or Workshop Item

Torgutalp, M., Azevedo, V., Baraliakos, X. et al. (39 more authors) (2024) Characteristics of Patients with Psoriatic Arthritis Presenting with Axial Involvement: Results of a Prospective International Multicenter Study (AXIS). In: ACR Convergence 2024, 14-19 Nov 2024, Washington, D. C..

Tillett, W.R., Coates, L., Vis, M. et al. (7 more authors) (2023) Early Improvement in 3 Visual Analogue Scale (3VAS)/4VAS Predicts Reduced Rates of Radiographic Change in Bio-naive Active Psoriatic Arthritis Patients Receiving Guselkumab Treatment. In: ACR Convergence 2023, 10-15 Nov 2023, San Diego, CA.

Tillett, W., Coates, L., Vis, M. et al. (7 more authors) (2023) POS1535 Early improvement in 3VAS/4VAS predicts reduced rates of radiographic change in bio-naive active psoriatic arthritis patients receiving Guselkumab treatment. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Proceedings Paper

Helliwell, P., Coates, L., Ransom, M. orcid.org/0000-0003-4359-8287 et al. (5 more authors) (2023) AB1147 The Comparative Performance of Three Screening Questionnaires for Psoriatic Arthritis in a Primary Care Surveillance Program. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 1803-1804.

Mchugh, N., Bojke, L., Coates, L. et al. (7 more authors) (2023) OP0271 Incidence of Psoriatic Arthritis and Prevalence of Undiagnosed Cases in a UK Primary Care Population Followed Prospectively For 2 Years - Results from the TUDOR Randomized Clinical Trial. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 178-179.

Brown, S., Coates, L., Collier, H. et al. (6 more authors) (2023) POS0224 Enhanced Surveillance for the Detection of Psoriatic Arthritis in a UK Primary Care Psoriasis Population Versus Usual Care: Results at 24 Months from the the Total Burden of Psoriasis (TUDOR) Randomised Control Trial. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. Suppl 1, 82 . BMJ Publishing Group , pp. 339-340.

Coyle, C., Watson, L., Brooke, M. et al. (25 more authors) (2023) P174 Psoriatic arthritis patients in the UK have a lower quality of life than patients in mainland Europe - an analysis from the ASSIST study. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

Tillett, W., Coates, L., Vis, M. et al. (9 more authors) (2023) P176 Minimal important difference, minimal detectable change and disease activity thresholds for two novel composite instruments, three visual analogue scale/VAS and four visual analogue scale/VAS, in patients with psoriatic arthritis: pooled analysis of three phase III studies. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

Tillett, W., Coates, L., Vis, M. et al. (9 more authors) (2022) 1017: Minimal Important Difference (MID), Minimal Detectable Change (MDC),and Disease Activity Thresholds for Two Novel Composite Instruments(3VAS, 4VAS) in Patients with Psoriatic Arthritis: Pooled Analysis of ThreePhase 3 Studies. In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 2013-2015.

Coyle, C., Whately-Smith, C., Brooke, M. et al. (24 more authors) (2022) 1028: How Does PsAID Implementation Affect Treatment Intensification and Patient Satisfaction in PsA? In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 2040-2042.

Tillett, W., Coates, L., Kishimoto, M. et al. (4 more authors) (2022) 1268: Evaluating Numeric Rating Scale Versions of the 3 and 4 Visual Analog Scale (3/4-VAS) Composite Measures in Patients with Active Psoriatic Arthritis from the SELECT-PsA Program. In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 2488-2490.

Yazji, S., Helliwell, P., Balanescu, A. et al. (13 more authors) (2022) 1496: Do Patients in MDA Report Low Disease Activity Regardless of Which of the MDA Criteria Are Met? In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 2954-2957.

Coates, L., Gossec, L., Contre, C. et al. (8 more authors) (2022) 2127: Guselkumab Provides Continued Improvement in Key Domains of Psoriatic Arthritis Through 2 Years. In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 4214-4216.

Tillett, W., Coates, L., Sharaf, M. et al. (7 more authors) (2022) 2142: Strong Correlation Between Short- vs Long-form Composite Measures ofPsoriatic Arthritis Disease Activity in a TNFi-IR Population Treated withGuselkumab: Data from the Phase 3b COSMOS Trial. In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 4248-4251.

Tillett, W., Coates, L., Kishimoto, M. et al. (4 more authors) (2022) AB0904 Evaluating Numeric Rating Scale Versions of the 3 and 4 Visual Analog Scale (3/4-VAS) Composite Measures in Patients with Active Psoriatic Arthritis from the SELECT-PsA Program. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 1580-1581.

Coates, L., Gossec, L., Contre, C. et al. (8 more authors) (2022) POS1017 Guselkumab Provides Continued Improvement In Key Domains Of Psoriatic Arthritis Through 2 Years. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 818-819.

Tillett, W., Coates, L., Neuhold, M. et al. (6 more authors) (2022) POS1043 Strong Correlation Between Short- Vs Long-Form Composite Measures Of Psoriatic Arthritis Disease Activity In A TNFi-IR Population Treated With Guselkumab: Data From The Phase 3b Cosmos Trial. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 838-839.

This list was generated on Tue Apr 1 17:57:05 2025 BST.